FDA OKs Late-Stage Breast Cancer Drug

Friday, 22 Feb 2013 12:27 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. health regulators said on Friday they have approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who have failed other therapies.
 
The U.S. Food and Drug Administration said it approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2.
 
The drug's label will carry a boxed warning, the most serious possible, of the drug's potential to cause liver and heart toxicity and death. The drug can also cause life-threatening birth defects.
 
In clinical trials, patients who took the drug, known during its development process as T-DM1, survived an average of 30.9 months, compared with 25.1 months in the control group.

Special: This Small Group of Doctors are Quietly Curing Cancer

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Two Ebola Patients Coming to US

Friday, 01 Aug 2014 17:12 PM

Two American aid workers, both seriously ill after being infected with the deadly Ebola virus in Liberia, will be flown  . . .

New Type 2 Diabetes Drug Gets FDA OK

Friday, 01 Aug 2014 16:11 PM

The U.S. Food and Drug Administration announced on Friday that itapproved a new drug, Jardiance, to help fight Type 2 di . . .

Why Isn't There a Vaccine or Treatment for Ebola?

Friday, 01 Aug 2014 16:01 PM

In the four decades since the Ebola virus was first identified in Africa, treatment hasn't changed much. There are no li . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved